Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: Complementary test of EBNA-1 with EA-D

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 5, 1997, Pages 363-368

  Chow, Kuan Chih ^a   Ma, Jeng ^d   Lin, Lung Seng ^d   Chi, Kwan Hwa ^a   Yen, Sang Hue ^a   Liu, Shian Min ^b   Liu, Wu Tse ^c   Chen, Wing Kai ^a   Chang, Tong Hsuan ^d   Chen, Kuang Y ^a,e  

^a Cancer Research Center   (Taiwan)

^b Division of Hematopathology   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GENE PRODUCT; VIRUS ANTIGEN;

ANTIGEN DETECTION; ARTICLE; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MASS SCREENING; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ADULT; AGED; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; MALE; MASS SCREENING; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RISK; TUMOR VIRUS INFECTIONS;

EID: 16944364831     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Zeng, Y. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou city, China. Int. J. Cancer, 29. 139-141, 1982.
2. Lynn, T-C., Tu, S-M., and Kawamura, A. Long-term follow-up of IgG and IgA antibodies against viral capsid antigens of Epstein-Barr virus in nasopharyngeal carcinoma. J. Laryngol. Otol., 99: 567-572, 1985.
3. Ho, H. C., Ng, M. H., Kwan, H. C., and Chau, J. C. W. Epstein-Barr virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Br. J. Cancer, 34: 655-660, 1976.
4. Can, Y. Y., Fones-Tan, A., Chan, S. H., Tsao, S. Y., Li, B., and Tan, W. H. Molecular cloning and expression of Epstein-Barr virus antigens the λ gt 11 expression vector: antibodies toward proteins from the BORF2 and BKRF4 reading frames in nasopharyngeal carcinoma patients. Intervirology, 199: 233-235, 1994.
5. Mathew, A., Cheng, H. M., Sam, C. K., Joab, I., Prasad, U., and Cochet, C. A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunol. Immunother., 38: 68-70, 1994.
6. Shu, M. M., and Huang, S. C. Prognostic factors of patients with nasopharyngeal carcinoma. Acta Otolaryngol., 458 (Suppl.): 34-40, 1988.
7. Desgranges, C., Bornkamm, G. W., Zeng, Y., Wang, P. C., Zhu, J. S., Shang, M., and de-The, G. Detection of Epstein-Barr viral DNA internal repeats in the nasopharyngeal mucosa of Chinese with IgA/EBV-specific antibodies. Int. J. Cancer, 29: 87-91, 1982.
8. Feinmesser, R., Miyazaki, I., Cheung, R., Freeman, J. L., Noyek, A. M., and Dosch, H. M. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N. Engl. J. Med., 326: 17-21, 1992.
9. Yeung, W. M., Zong, Y. S., Chiu, C. T., Chan, K. H., Sham, J. S. T., Choy, D. T. K., and Ng, M. H. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int. J. Cancer, 53: 746-750, 1993.